Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe, North America and Asia. The aim of this observational
study is to evaluate the safety and effectiveness while using Levemir® once daily in
combination with oral antidiabetic drugs in type 2 diabetics during 24 weeks under normal
clinical practice.
Data from the NN304-3573 study (NCT00740519) will be pooled with data from this study and
reported together in the final study report for this study.